Private company
Calliditas Therapeutics AB
Last updated Oct 16, 2026.
Overview
-466.2MNet income, fiscal 20232
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
-$447.4MFree cash flow2
Financial statements
No quarterly figures reported.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Gross profit | 874.0K SEK4 | 229.3M SEK2 | 787.7M SEK2 | 1.1B SEK2 | |||
| Operating income | -132.5M SEK5 | -28.0M SEK6 | -379.7M SEK4 | -524.5M SEK2 | -421.9M SEK2 | -373.1M SEK2 | |
| Net income | -132.0M SEK5 | -32.6M SEK6 | -436.5M SEK4 | -509.5M SEK2 | -412.3M SEK2 | -466.2M SEK2 | |
| Earnings per share | -$0.886 | -$9.666 | -$9.846 |
No quarterly figures reported.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | 57.4M SEK5 | 646.2M SEK6 | 753.5M SEK4 | 996.3M SEK2 | 955.5M SEK2 | 1.2B SEK2 | 973.7M SEK2 |
| Total assets | 845.2M SEK5 | 1.5B SEK6 | 1.5B SEK4 | 2.0B SEK2 | 1.9B SEK2 | ||
| Shareholders’ equity | 33.2M SEK5 | 618.2M SEK6 | 788.1M SEK4 | 1.3B SEK4 | 1.0B SEK4 | 766.3M SEK4 | |
| Shares outstanding | 49.9M shares5 | 52.3M shares6 | 59.6M shares4 | 59.6M shares2 |
Recent filings
- Sep 3, 20246-K
- Aug 13, 20246-K
- Jul 31, 20246-K
- Jul 26, 20246-K
- Jun 17, 20246-K
- May 30, 20246-K
- May 28, 20246-K
- May 23, 20246-K
- May 16, 20246-K
- May 6, 20246-K
- Apr 25, 20246-K
- Apr 24, 202420-F
- Mar 6, 20246-K
- Feb 21, 20246-K
- Jan 8, 20246-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6